Literature DB >> 21311980

Primary aldosteronism: A contrarian view.

Norman M Kaplan1.   

Abstract

This paper provides evidence that primary aldosteronism is likely much less common than is believed by the other authors of this collection. The basis for this contrarian view is simple: there is no way to know the true prevalence of PA because of the uncertain validity of all of the diagnostic procedures used to find and characterize this disease. Moreover, even if these uncertainties are overcome, the eventual treatment of most who have PA can be provided without the need for extensive testing and expensive treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21311980     DOI: 10.1007/s11154-011-9160-x

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  25 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.

Authors:  Stella Douma; Konstantinos Petidis; Michael Doumas; Panagiota Papaefthimiou; Areti Triantafyllou; Niki Kartali; Nikolaos Papadopoulos; Konstantinos Vogiatzis; Chrysanthos Zamboulis
Journal:  Lancet       Date:  2008-06-07       Impact factor: 79.321

3.  Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism.

Authors:  Paolo Mulatero; Chiara Bertello; Norlela Sukor; Richard Gordon; Denis Rossato; Nicholas Daunt; David Leggett; Giulio Mengozzi; Franco Veglio; Michael Stowasser
Journal:  Hypertension       Date:  2010-02-01       Impact factor: 10.190

4.  Saline suppression of plasma aldosterone in hypertension.

Authors:  D C Kem; M H Weinberger; D M Mayes; C A Nugent
Journal:  Arch Intern Med       Date:  1971-09

5.  How common is primary aldosteronism? Is it the most frequent cause of curable hypertension?

Authors:  R D Gordon; S A Klemm; M Stowasser; T J Tunny; W J Storie; J C Rutherford
Journal:  J Hypertens Suppl       Date:  1993-12

Review 6.  Primary aldosteronism: management issues.

Authors:  William F Young
Journal:  Ann N Y Acad Sci       Date:  2002-09       Impact factor: 5.691

7.  High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.

Authors:  Michael Stowasser; Richard D Gordon; Thanuja G Gunasekera; Diane C Cowley; Gregory Ward; Colin Archibald; B Mark Smithers
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

8.  Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism.

Authors:  Francesca Pizzolo; Ricciarda Raffaelli; Alessia Memmo; Laura Chiecchi; Chiara Pavan; Patrizia Guarini; Gian Cesare Guidi; Massimo Franchi; Roberto Corrocher; Oliviero Olivieri
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

9.  Update in primary aldosteronism.

Authors:  Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2009-09-08       Impact factor: 5.958

Review 10.  Primary aldosteronism. Issues in diagnosis and management.

Authors:  E L Bravo
Journal:  Endocrinol Metab Clin North Am       Date:  1994-06       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.